An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an international normalised ratio above 10.0

Thrombosis and Haemostasis

Volumn 101, Issue 2, 2009, Pages 410-411

  Denas, Gentian ^a   Cucchini, Umberto ^a   Iliceto, Sabino ^a   Pengo, Vittorio ^a,b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Thrombosis Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; BLEEDING; DIET; DRUG EFFICACY; DRUG RESISTANCE; DRUG SAFETY; EPISTAXIS; FEMALE; FOLLOW UP; HEMATURIA; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELENA; NON VALVULAR ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; OVERANTICOAGULATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECTUM HEMORRHAGE; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; BLOOD CLOTTING; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROTHROMBIN TIME; VITAMIN K 1; WARFARIN;

EID: 62449233299     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-0251     Document Type: Letter

References (8)

1. Denas G, Marzot F, Offelli P, et al. Effectiveness and safety of a management protocol to correct over-anti-coagulation with oral vitamin K: a retrospective study of 1,043 cases, J Thromb Thrombolysis 2008; in print.
2. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
3. Dentali F, Ageno W. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review. Haematologiea 2004; 89: 857-862.
4. Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'Malley P G. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med 2006; 166: 391-397.
5. Libby EN, Garcia DA. A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med 2002; 162: 1893-1896.
6. Gunther KE, Conway G, Leibach L, et al. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Thromb Res 2004; 113:205-209.
7. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S-198.
8. Makris M, Watson HG. The management of coumarin-induced over-anticoagulation. Annotation. Br J Haemat 2001; 114: 271-280.